Vector-borne diseases (VBDs) pose a significant threat to public health in India, driven by a combination of environmental, socio-economic, and healthcare factors. This article provides an in-depth analysis of the situation and suggests strategies for combatting this rising tide.
VBDs, such as dengue, malaria, and chikungunya, account for more than 17% of all infectious diseases in India. They contribute to economic instability and increased healthcare costs. The country's vast population, coupled with inadequate health infrastructure and environmental factors, make VBDs a persistent challenge.
Efforts to control VBDs are hampered by a variety of factors. These include rapid urbanization, climate change, and the lack of access to clean water and sanitation. The widespread use of insecticides has also led to the emergence of resistant vector species, further complicating control measures.
Effective control of VBDs requires a multi-faceted approach. This includes strengthening health infrastructure, improving surveillance systems, and promoting community involvement. Integrated vector management (IVM) strategies, which combine chemical and biological control methods with habitat modification, can also be highly effective.
Healthcare professionals have a crucial role in controlling VBDs. They are pivotal in early detection, prompt treatment, and patient education. Their involvement in policy-making can also contribute to the development of more effective, sustainable strategies for VBD control.
Combatting the rising tide of VBDs in India requires a comprehensive, coordinated approach. By strengthening healthcare systems, implementing effective vector control strategies, and leveraging the expertise of healthcare professionals, it is possible to mitigate the impact of these diseases and protect public health.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation